Medifast Inc (MED) Issues Q4 Earnings Guidance
Medifast Inc (NYSE:MED) issued an update on its fourth quarter earnings guidance on Tuesday morning. The company provided EPS guidance of $0.46-0.49 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.47. The company issued revenue guidance of $71.4-74.4 million, compared to the consensus revenue estimate of $73.23 million.
Several analysts have recently issued reports on the stock. DA Davidson assumed coverage on shares of Medifast in a research report on Wednesday, August 16th. They issued a buy rating on the stock. BidaskClub upgraded shares of Medifast from a sell rating to a hold rating in a research report on Saturday, August 19th. Finally, Sidoti reiterated a neutral rating and issued a $55.00 target price (up previously from $49.00) on shares of Medifast in a research report on Thursday, September 21st.
Shares of Medifast Inc (NYSE MED) traded down $0.07 during midday trading on Tuesday, hitting $61.19. 145,590 shares of the stock traded hands, compared to its average volume of 88,951. The firm has a market cap of $733.70, a price-to-earnings ratio of 30.91, a price-to-earnings-growth ratio of 1.93 and a beta of 0.45.
Medifast (NYSE:MED) last announced its earnings results on Tuesday, November 7th. The specialty retailer reported $0.55 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.51 by $0.04. Medifast had a net margin of 8.62% and a return on equity of 24.25%. The business had revenue of $77.20 million for the quarter, compared to analyst estimates of $74.94 million. During the same quarter last year, the business earned $0.51 earnings per share. The company’s revenue for the quarter was up 12.5% compared to the same quarter last year. sell-side analysts predict that Medifast Inc will post 2.12 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 9th. Investors of record on Friday, September 22nd will be given a dividend of $0.32 per share. The ex-dividend date of this dividend is Thursday, September 21st. This represents a $1.28 dividend on an annualized basis and a yield of 2.09%. Medifast’s payout ratio is presently 64.32%.
Medifast Company Profile
Medifast, Inc is engaged in the production, distribution and sale of weight loss, weight management and healthy living products, and other consumable health and nutritional products. Medifast product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products and vitamins.
Receive News & Ratings for Medifast Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medifast Inc and related companies with MarketBeat.com's FREE daily email newsletter.